
The results of a clinico-laboratory evaluation of general response of cancer patients to antitumor therapy, including modificators, are considered. Also, applications of some procedures as guides to prognosis as well as the results of studies bacterial immunity and methods of its stimulation to prevent purulent complications in cancer patients are discussed.

